Qual é o preço para Broncus Holding Corporation (2216)

O preço para Broncus Holding Corporation (2216) é $0.08123316

Qual é a capitalização de mercado para Broncus Holding Corporation (2216)

A capitalização de mercado para Broncus Holding Corporation (2216) é $42.78M

Histórico de Preços de Broncus Holding Corporation (2216)

Broncus Holding Corporation is a global medical technology company specializing in the development of interventional pulmonology products. Its market reach extends across Mainland China, the European Union, the United States, and other international territories. The company's innovative product lineup includes advanced navigation systems such as LungPoint Virtual Bronchoscopic Navigation, a sophisticated computer-assisted image-based software solution. It also offers LungPoint Plus, a system providing real-time airway guidance crucial for lung biopsies and other medical interventions, and LungPro, a virtual bronchoscopic navigation product that enables three-dimensional real-time guided transbronchial needle aspiration alongside proprietary parenchymal navigation. Beyond navigation, Broncus provides a suite of therapeutic products. These feature InterVapor, a targeted bronchoscopic thermal vapor ablation system designed to treat diseased, hyper-inflated lung segments. Additionally, it offers an RF Generator paired with an RF Ablation Catheter, forming a radiofrequency ablation system specifically developed to target lung cancer. The H-Marker, a pulmonary surgical marker, is another key offering. The company further supplies a range of specialized procedural devices, including the BioStarNeedle, a single-use ultrasound-guided aspiration needle for retrieving tissue samples, and the FleXNeedle, a versatile multipurpose biopsy needle. Complementing these are various bronchoscopic accessories like the Archimedes Sheath, a sterile, single-use flexible tube that serves as a working channel during bronchoscopic procedures. The Archimedes Dilation Balloon, another sterile, single-use flexible tube with a distal balloon, is used to dilate target lung tissue within the bronchial tree after insertion through a bronchoscope or sheath. Finally, the Steerable Sheath provides a steerable adjustment handle and an additional working channel. Broncus Holding Corporation was established in 2012 and maintains its corporate headquarters in Hangzhou, China.

Ano	Desempenho
2026 (TTM)	-24.46%
2025	332.07%
2024	-25.34%
2023	-68.86%
2022	-73.15%
2021	0.00%

Ano

Desempenho

2026 (TTM)

-24.46%

2025

332.07%

2024

-25.34%

2023

-68.86%

2022

-73.15%

2021

0.00%

Empresa	Preço da ação	Variação 1a%	País
Abbott Laboratories ABT.US	$114.62	-13.46%	US
Stryker Corporation SYK.US	$333.30	-14.95%	US
Medtronic plc MDT.US	$92.85	-0.40%	IE
Boston Scientific Corporation BSX.US	$50.10	-52.76%	US
Siemens Healthineers AG SHL.DE	$47.22	-15.86%	DE

Empresa

Preço da ação

Variação 1a%

País